| 1. | Deutsche Gesellschaft für Urologie (DGU). Leitlinien der Deutschen Gesellschaft für Urologie (DGU) und des Berufsverbands der Deutschen Urologen (BDU): Therapie des Benignen Prostatasyndroms (BPS). http://www.awmf.org/uploads/tx_szleitlinien/043-035l_S2e_Benignes_Prostatasyndrom_Therapie_Leitlinientext.pdf |
| 2. | Kortmann BB, Floratos DL, Kiemeney LA, Wijkstra H, de la Rosette JJ: Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials. Urology 2003; 62: 1–9. CrossRef MEDLINE |
| 3. | Roehrborn CG, Schwinn DA: Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol 2004; 171: 1029–35. CrossRef MEDLINE |
| 4. | Oelke M, BachmannA, Descazeaud A, et al.: Guidelines on the treatment of non-neurogenic male LUTS. European Association of Urology 2011. |
| 5. | Sterrett SP, Nakada SY: Medical expulsive therapy. Curr Opin Urol 2008; 18: 210–3. CrossRef MEDLINE |
| 6. | Chang DF: Use of Malyugin pupil expansion device for intraoperative floppy-iris syndrome: results in 30 consecutive cases. J Cataract Refract Surg 2008; 34: 835–41. CrossRef MEDLINE |
| 7. | Chang DF, Braga-Mele R, Mamalis N, et al.: Clinical experience with intraoperative floppy-iris syndrome: results of the 2008 ASCRS member survey. J Cataract Refract Surg 2008; 34: 1201–9. CrossRef MEDLINE |
| 8. | Hieble JP, Bylund DB, Clarke DE, et al.: International Union of Pharmacology. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev 1995; 47: 267–70. MEDLINE |
| 9. | Pärssinen O, Leppänen E, Keski-Rahkonen P, Mauriala T, Dugué B, Lehtonen M: Influence of tamsulosin on the iris and its implications for cataract surgery. Invest Ophthalmol Vis Sci 2006; 47: 3766–71. CrossRef MEDLINE |
| 10. | Sallam A, Gunasekera V, Kashani S, Toma M: Awareness of IFIS among primary care physicians. J Cataract Refract Surg 2008; 34: 882. CrossRef MEDLINE |
| 11. | Prata TS, Palmiero PM, Angelilli A, et al.: Iris morphologic changes related to alpha one adrenergic receptor antagonists: implications for floppy iris syndrome. Ophthalmology 2009; 116: 877–81. CrossRef MEDLINE PubMed Central |
| 12. | Palea S, Chang DF, Rekik M, et al.: Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles: possible model for intraoperative floppy iris syndrome. J Cataract Refract Surg 2008; 34: 489–96. CrossRef MEDLINE |
| 13. | Chang DF, Campbell JR: Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 2005; 31: 664–73. CrossRef MEDLINE |
| 14. | Abdel-Aziz S, Mamalis N: Intraoperative floppy iris syndrome. Curr Opin Ophthalmol 2009; 20: 37–41. CrossRef MEDLINE |
| 15. | Chang DF, Braga-Mele R, Mamalis N, et al.: ASCRS Cataract Clinical Committee. ASCRS White Paper: clinical review of intraoperative floppy-iris syndrome. J Cataract Refract Surg 2008; 34: 2153–62. CrossRef MEDLINE |
| 16. | Mamalis N: Intraoperative floppy-iris syndrome associated with systemic alpha blockers. J Cataract Refract Surg 2008; 34: 1051–2. CrossRef MEDLINE |
| 17. | Chatziralli IP, Sergentanis TN: Risk factors for intraoperative floppy iris syndrome: A meta-analysis. Ophthalmology 2011; 118: 730–5. CrossRef MEDLINE |
| 18. | Flach AJ: Intraoperative floppy iris syndrome: pathophysiology, prevention, and treatment. Trans Am Ophthalmol Soc 2009; 107: 234–9. MEDLINE PubMed Central |
| 19. | Masket S, Belani S: Combined preoperative topical atropine sulfate 1% and intracameral nonpreserved epinephrine hydrochloride 1:4000 for management of intraoperative floppy-iris syndrome. J Cataract Refract Surg 2007; 33: 580–2. CrossRef MEDLINE |
| 20. | Shugar JK: Use of epinephrine for IFIS prophylaxis. J Cataract Refract Surg 2006; 32: 1074–5. CrossRef MEDLINE |
| 21. | Santaella RM, Destafeno JJ, Stinnett SS, Proia AD, Chang DF, Kim T: The effect of alpha1-adrenergic receptor antagonist tamsulosin (Flomax) on iris dilator smooth muscle anatomy. Ophthalmology 2010; 117: 1743–9. Epub 2010 May 13. CrossRef MEDLINE |
| 22. | Chang DF, Osher RH, Wang L, Koch DD: Prospective multicenter evaluation of cataract surgery in patients taking tamsulosin (Flomax). Ophthalmology 2007; 114: 957–64. CrossRef MEDLINE |
| 23. | Chang DF: Floppy iris syndrome: why BPH treatment can complicate cataract surgery. Am Fam Physician 2009; 79: 1055–6. MEDLINE |
| 24. | Michel MC, Pfeiffer N, Höfner K: Was bedeutet das „intraoperative floppy iris“ Syndrom für den Urologen? Urologe A 2006; 45: 1547–8. CrossRef MEDLINE |
| 25. | Simpson D, Munshi S, Dhar-Munshi S: Intra-operative floppy iris syndrome-a warning for geriatricians. Age Ageing 2010; 39: 516. Epub 2010 May 19. CrossRef MEDLINE |
| e1. | Roehrborn CG: Three months' treatment with the alpha1-blocker alfuzosin does not affect total or transition zone volume of the prostate. Prostate Cancer Prostatic Dis 2006; 9: 121–5. CrossRef MEDLINE |
| e2. | Berry SJ, Coffey DS, Walsh PC, Ewing LL: The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–9. MEDLINE |
| e3. | Zwergel T, Zwergel U: Benignes Prostatasyndrom. In: Jocham D, Miller K, eds.: Praxis der Urologie, Band II. Stuttgart, New York: Thieme 2007: 249. |
| e4. | Gurbaxani A, Packard R: Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin. Eye (Lond) 2007; 21: 331–2. CrossRef MEDLINE |
| e5. | Suzuki F, Taniguchi T, Nakamura S, et al.: Distribution of alpha-1 adrenoceptor subtypes in RNA and protein in rabbit eyes. Br J Pharmacol 2002; 135: 600–8. MEDLINE |
| e6. | Richardson CD, Donatucci CF, Page SO, et al.: Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes. Comparison with alfuzosin, doxazosin, prazosin, and terazosin. Prostate 1997; 33: 55–9. MEDLINE |
| e7. | Bell CM, Hatch WV, Fischer HD, et al.: Association between tamsulosin and serious ophthalmic adverse events in older men following cataract surgery. JAMA 2009; 301: 1991–6. MEDLINE |
| e8. | Herd MK: Intraoperative floppy-iris syndrome with doxazosin. J Cataract Refract Surg 2007; 33: 562. CrossRef |
| e9. | Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ: EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004; 46: 547–4. CrossRef MEDLINE |
| e10. | Casuccio A, Cillino G, Pavone C, Spitale E, Cillino S: Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome.J Cataract Refract Surg 2011; 37: 1447–54. MEDLINE |
| e11. | Oshika T, Ohashi Y, Inamura M, et al.: Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha(1)-adrenoceptor antagonist. Am J Ophthalmol 2007; 143: 150–1. MEDLINE |
| e12. | Yu Y, Koss MC: Studies of alpha adrenoceptor antagonists on sympathetic mydriasis in rabbits. J Ocul Pharmacol Ther 2003; 10: 255–63. MEDLINE |
| e13. | Panagis L, Basile M, Friedman AH, Danias J: Intraoperative floppy iris syndrome: report of a case and histopathologic analysis. Arch Ophthalmol 2010; 128: 1437–41 MEDLINE . |
| e14. | Blouin MC, Blouin J, Perreault S, Lapointe A, Dragomir A: Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin. J Cataract Refract Surg 2007; 33: 1227–34. MEDLINE |
| e15. | Schwinn DA, Afshari NA: alpha(1)-Adrenergic receptor antagonists and the iris: new mechanistic insights into floppy iris syndrome. Surv Ophthalmol 2006; 51: 501–12. CrossRef MEDLINE |
| e16. | Cantrell MA, Bream-Rouwenhorst HR, Steffensmeier A, Hemerson P, Rogers M, Stamper B: Intraoperative floppy iris syndrome associated with alpha1-adrenergic receptor antagonists. Ann Pharmacother. 2008; 42: 558–63. MEDLINE |
| e17. | Chen AA, Kelly JP, Bhandari A, Wu MC: Pharmacologic prophylaxis and risk factors for intraoperative floppy-iris syndrome in phacoemulsification performed by resident physicians. J Cataract Refract Surg 2010; 36: 898–905. MEDLINE |
| e18. | Cheung CM, Awan MA, Peh KK, Sandramouli S: Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha1-adrenoceptor antagonist. Am J Ophthalmol 2007; 143: 1070; author reply 1070–1. MEDLINE |
| e19. | Chadha V, et al.: Floppy iris behaviour during cataract surgery: associations and variations. Br J Ophthalmol 2007; 91: 40–2. MEDLINE |
| e20. | Storr-Paulsen A, Nørregaard JC, Børme KK, Larsen AB, Thulesen J: Intraoperative floppy iris syndrome (IFIS): a practical approach to medical and surgical considerations in cataract extractions. Acta Ophthalmol 2009; 87: 704–8. CrossRef MEDLINE |
| e21. | Bendel RE, Phillips MB: Preoperative use of atropine to prevent intraoperative floppy-iris syndrome in patients taking tamsulosin. J Cataract Refract Surg 2006; 32: 1603–5. CrossRef MEDLINE |
| e22. | Lockington D, Gavin MP: Intraoperative floppy-iris syndrome: role of the bimanual approach. J Cataract Refract Surg 2009; 35: 964. CrossRef MEDLINE |
| e23. | Moore SP, Goggin M: Intraoperative floppy iris syndrome and microincision cataract surgery. J Cataract Refract Surg 2010; 36: 2008. CrossRef MEDLINE |
| e24. | Barkin J, et al.: Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5??reductase inhibitor dutasteride. Eur Urol 2003; 44: 461–6. MEDLINE |
| e25. | Al-Hussaini ZK, McVary KT: Alpha-blockers and intraoperative floppy iris syndrome: ophthalmic adverse events following cataract surgery. Curr Urol Rep 2010; 11: 242–8. CrossRef MEDLINE |
| e26. | Facio F, Kashiwabuschi R, Nishi Y, Leao R, McDonnell P, Burnett A: Benign prostatic hyperplasia. Clinical treatment can complicate cataract surgery. Int Braz J Urol 2010; 36: 563–70. MEDLINE |
| e27. | González Martín-Moro J, Santos Arrontes D, et al.: What urologists know about intraoperative floppy-iris syndrome. J Cataract Refract Surg 2010; 36: 2006–7. MEDLINE |
| e28. | Yaycioglu O, Altan-Yaycioglu R. Intraoperative floppy iris syndrome: facts for the urologist. Urology. 2010; 76: 272–6. MEDLINE |